About SentreHEART
SentreHEART is a Healthcare company based in Redwood City (United States) founded in 2005, and was acquired by AtriCure in August 2019. Suture-based devices for soft tissue closure are developed. SentreHEART has raised $69.02 million across 4 funding rounds from investors including AtriCure, Deerfield and USVP. Its focus areas include Life Sciences, Surgical Instruments, Surgical Access and Closure and Surgical Sutures. Its competitors include Ceterix, Tepha and SuturTek Incorporated; 3 of its 3 listed competitors have raised funding.
Company details
SentreHEART was founded in 2005 and is based in Redwood City, United States. Medical devices focused on cardiovascular applications are produced, including a suture delivery system that enables remote closure of soft tissues without residual metal, clips, or implants. Additional components such as occlusion balloons, guide cannulas, guide wire systems, suture tighteners, and suture cutters are offered to support these procedures. Operations center on innovation in minimally invasive closure technologies.
- Headquarters Redwood City, United States
- Stage Acquired
- SectorsHealthcare
- Website sentreheart.com
- Social LinkedIn
- Acquired by AtriCure (Aug 2019)
Funding Insights of SentreHEART
SentreHEART has successfully raised a total of $69.02M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $35 million completed in October 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $69.02M
- Total Rounds 4
- Last Round Series D — $35M
- First Round $2.03M
(Aug 2005)
- Investors Count 5
All 4 funding rounds of SentreHEART with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2016 | $35M | Series D | – | Deerfield | |
| Jun 2012 | $26M | Series C | – | Vivo Capital | |
| Jan 2007 | $6M | Series B | – | – | – |
| Aug 2005 | $2.03M | Series A | – | – | – |
6 investors in total: 6 institutional.
Investors in SentreHEART
SentreHEART has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include AtriCure, Deerfield and USVP.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare ecosystem is supported through investment and innovation by Deerfield. | deerfield.com | New York, United States | ||
VC firm that focuses on early stage investments in the US | usvp.com | Menlo Park, United States | ||
Investments are made in US life sciences and healthtech firms. | prospectventures.com | Palo Alto, United States | ||
Venture capital and private equity firm | vivocapital.com | Palo Alto, United States | ||
Venture capital firm focused on life science and technology sectors | decheng.com | Shanghai, China | ||
Cardiac ablation and occlusion devices for atrial fibrillation are provided. | 2000 | atricure.com | Mason, United States |
Investor details for SentreHEART
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of SentreHEART
4 dated milestones of SentreHEART across 14 years, from founding to its latest funding, stage changes and deals.
- Founded SentreHEART is founded.
- Funding First funding round of $2.0M.
- Funding Latest funding round, Series D, of $35.0M.
- Exit Acquired by AtriCure.
Competitors of SentreHEART
SentreHEART has 3 listed competitors in our database, 3 of them funded. They include Ceterix, Tepha and SuturTek Incorporated.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ceterix.com | 2010 | Menlo Park, United States | $73.88M | 63 | Novel suture passers for arthroscopic orthopedic surgery are developed. | |
| tepha.com | 1998 | Lexington, United States | $36.31M | 51 | Absorbable biomaterials for medical sutures and meshes are developed. | |
| suturtek.com | 1993 | Chelmsford, United States | $1.4M | Suturing devices are supplied for open and minimally invasive surgery. |
Detailed competitors of SentreHEART
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Medical Equipment & Supplies
3 companies that operate in the same segment as SentreHEART (Medical Equipment & Supplies) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Robotic waterjet system for prostate tissue removal is developed. | 2009 | Redwood City, California, United States | USD 348.84 M | USD 308.05 M | 756 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 | ||
Injectable packaging, containment, and delivery solutions are manufactured. | 1923 | Exton, Pennsylvania, United States | USD 3.07 B | 10,600 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sentreheart
Complete news archive for SentreHEART
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SentreHEART
SentreHEART was founded in 2005.
SentreHEART is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
SentreHEART is a funded company, having raised a total of $69.02M across 4 funding rounds to date. The company's 1st funding round was a Series A of $2.03M, raised on Aug 2005.
SentreHEART was founded in 2005 and is based in Redwood City, United States. Medical devices focused on cardiovascular applications are produced, including a suture delivery system that enables remote closure of soft tissues without residual metal, clips, or implants. Additional components such as occlusion balloons, guide cannulas, guide wire systems, suture tighteners, and suture cutters are offered to support these procedures. Operations center on innovation in minimally invasive closure technologies.
SentreHEART's top competitors include Ceterix, Tepha and SuturTek Incorporated.
SentreHEART has 6 investors. Key investors include AtriCure, Deerfield, USVP, Prospect Venture Partners, and Vivo Capital.
Yes. SentreHEART was acquired by AtriCure in August 2019.